GenSight Biologics S.A.
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its pr…
Biotechnology
FR, Paris [HQ]
FR · Macroeconomic Factors/Risks · Forecasts
Macro
FR · Macroeconomic Factors/Risks · ForecastsGenSight Biologics S.A. mainly operates in FR (Alpha-2: FR, Alpha-3: FRA)
France
Analysis Results
B Overall Rating
20 Analyzed Indicators
B Annual Indicators Rating
17 Analyzed Indicators
A Monthly Indicators Rating
3 Analyzed Indicators
Likelihood Legend A++ is best, F- worst
- A++
- A+
- A
-
Very Unlikely - B+
- B
-
Unlikely
- C+
- C
- D+
- D
- D-
-
Avg.
- E+
- E-
-
Unlikely - F+
- F
- F-
-
Very Unlikely
Indicator
All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.
Rating